Myelin: a giant membrane organelle with specific lipid characteristics
The rapid saltatory conduction of action potentials along axons is crucially dependent on myelination. The myelin membrane is an extended and highly specialized plasma membrane synthesized by myelinating glial cells: oligodendrocytes in the central nervous system (CNS), and Schwann cells in the peripheral nervous system (PNS) (Figure 1) . The wrapping of myelin around an axonal segment increases axonal diameter and enables clustering of axonal ion channels at nodes of Ranvier (1) . As such, myelinating glial cells shape the structural and electrical properties of axons resulting in a 10-to 100-fold increase in nerve conduction velocity (2, 3) , and in a great reduction of axonal energy consumption (4) .
One of the prominent biochemical characteristics that distinguishes myelin from other membranes is its high lipid-to-protein ratio: lipids account for at least 70% of the dry weight of myelin membranes ( Table 1) which is also the physical basis for its biochemical purification by sucrose gradient centrifugation (5) .
The myelin membrane contains myelin-specific proteins (e.g. myelin basic protein, myelin associated glycoprotein and proteolipid protein), but no truly myelinspecific lipids. Nevertheless, whereas all major lipid classes are present in myelin as in other membranes, myelin has its characteristic lipid composition. The myelin membrane contains a high level of cholesterol of at least 26% by weight (or 52 mole%) ( Table 1 ) (6, 7) . The importance of cholesterol for myelin production and maintenance has recently been reviewed (8) . The myelin membrane is also substantially enriched in galactolipids (31% versus 7% for liver cell plasma membranes). Two glycosphingolipids, the monogalactosylsphingolipids cerebroside (Gal-C) and sulfatide (SGal-C) account for 14-26% and 2-7% of myelin lipids, respectively (9) (10) (11) . When compared to hepatocyte and erythrocyte membranes, myelin membranes also contain a higher proportion of saturated long-chain fatty acids (Figure 2) . Finally, the lipid content of myelin is also enriched in plasmalogens (etherlipids). These glycerophospholipids, defined by a vinyl ether double bond at the sn-1 position, account for 20% of the myelin phospholipid mass (compared to 18% in the average human phospholipid mass). Here, 70% of the total phosphatidylethanolamine (PE) in white matter is plasmalogen, in contrast to only 5% in liver (12, 13) . These lipid characteristics of myelin, together with the presence of myelin-specific proteins, are likely required for myelin wrapping and/or to confer the specific biophysical properties of myelin as an electrical "insulator", as will be discussed below.
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During development of the human nervous system, myelination starts in the motor roots of the PNS (fifth fetal month) and is followed by myelination of the spinal cord and brain (CNS). The majority of myelin is assembled during the first two years of postnatal life (14) , but myelination continues for 2-3 decades in the human cerebral white matter (15, 16) . In rodents, myelination occurs predominantly during the first month of life (17) . The magnitude of the tasks that glial cells have to accomplish in a short period of time is easily appreciated when visualizing the membrane expansion taking place during myelination (Figure 1 ). In rodents, it has been estimated that the myelin-membrane surface area of one glial cell expands at a rate of 5-50 × 10 3 μm 2 /day, compared with the surface area of the cell soma (i.e., the plasma membrane) of approx. 0.3 × 10 3 μm 2 (18) . This corresponds to an estimated 6500-fold increase in membrane surface between an immature and a fully myelinated oligodendrocyte (19) . In rodents, the expansion of the myelin membrane correlates with substantial accumulation of cholesterol and lipids in both the developing CNS and PNS (17, (20) (21) (22) . More recently, transcriptional profiling of developing peripheral nerves shed light on the molecular cascades involved in PNS myelin assembly (23, 24) . It was observed that transcripts encoding structural myelin proteins and enzymes involved in myelin lipid biosynthesis were expressed in a highly synchronized and timely fashion, suggesting a strict control of a balanced and local production of these two key components of myelin assembly. Relatively little is known about myelin lipid turnover in vivo, but studies in mice indicate a necessity to renew myelin lipids in adult life (25) .
Myelin defects in inherited diseases affecting lipid metabolism
The lipid-rich composition of myelin is likely to contribute to the frequent occurrence of myelin defects in lipid metabolism disorders, with myelin defects varying from hypomyelination (decreased myelin production), dysmyelination (abnormally formed myelin) to demyelination (degenerative loss of myelin). Inherited forms of these diseases are particularly informative and provide direct insight into the underlying molecular mechanisms. These involve defects in metabolism of all myelin enriched lipids: cholesterol, glycosphingolipid and long chain fatty acids ( Table 2 ). In several of these disorders the defects are caused by lipotoxicity, a result of the accumulation of various metabolic precursors involved in lipid biosynthesis to levels that are toxic to the myelinating glial cells or at least interfere with normal myelin membrane structure (reviewed in (26) (27) (28) 
Cholesterol disorders:
At least three different cholesterol related disorders cause defects in myelin (Table 2) , Of these, Cerebrotendinous xanthomatosis (CTX) and Tangier disease (TD) lead to accumulation of 7α-hydroxy-4-cholesten-3-one and cholestanol (in CTX) and cholesterolesters (in TD), which are likely to underlie the myelin pathology ((29-32), Figure 3 ). Myelin defects due to reduced cholesterol levels are possibly found in Smith-Lemli-Opitz syndrome (SLOS), which is caused by mutations in the gene encoding sterol delta-7-reductase (DHCR7), the enzyme catalyzing the last step of cholesterol biosynthesis. This results in the elevation of the cholesterol precursors 7-dehydro-cholesterol (7-DHC) and 8-dehydro-cholesterol (8-DHC) and in cholesterol deficiency in all tissues (33) (34) (35) . Patients with SLOS have multiple malformations, cognitive impairment, and behavioral deficits. CNS defects in white matter abnormalities are common, often involving corpus callosum absence or hypoplasia (36) (37) (38) (39) (40) (41) (42) , and reported to involve absence of myelin (42) and demyelination (43), but detailed analysis of myelin structure have not yet been described. The relative contribution of either cholesterol depletion or 7-DHC and 8-DHC accumulation in white matter abnormalities is currently unclear. Interestingly, dietary cholesterol supplementation has become the standard therapy for SLOS and was reported to partially improve the neurological status and white matter lipid abnormalities in some patients (36, (44) (45) (46) . Remarkably, PNS myelin defects are rarely reported for SLOS.
The reason for this is currently unclear, but dietary lipid supplementation has also been reported to improve a case of SLOS-associated demyelinating polyneuropathy (47) .
Mouse models of cholesterol disorders
Multiple mouse models of SLOS recapitulate morphological and biochemical aspects of the neuropathology of SLOS patients (48) (49) (50) . While ventricular dilatation and partial agenesis of corpus callosum was observed in one of these models (50), the status of myelination was so far not analyzed in DHCR7 mutant animals. may be related to the low amounts of cholesterol that are still produced in some forms of SLOS (33) and/or to the position of the defects in disruption of the cholesterol biosynthesis pathway which is more upstream in SQS mouse mutants.
While the amount of myelin in SQS conditional mutants was decreased, its ultrastructure, lipid and protein composition were not affected, suggesting a tight control mechanism matching the amount of myelin proteins produced by glial cells to the available cholesterol. Interestingly, both hypomyelination and motor deficits improved over time. These observations suggest that cell autonomous synthesis of cholesterol in oligodendrocytes is crucial for normal onset and progression of myelination. Cholesterol biosynthesis deficient oligodendrocytes are, however, able to take up some cholesterol from their surrounding for limited myelin formation (51) .
The exact mechanism of this horizontal cholesterol transfer remains to be clarified. In the PNS, the inactivation of cholesterol biosynthesis in Schwann cells also led to 
Glycosphingolipid disorders:
Most of the myelin defects in glycosphingolipid disorders are due to accumulation of glycosphingolipids or their precursors ( (59) . Surprisingly, the FA2H mutations result in demyelination of the CNS, while PNS myelin abnormalities are not found, suggesting there is a second fatty acid 2-hydroxylating activity in human Schwann cells (57) .
Mouse models of glycosphingolipid disorders:
FA2H deficient mouse mutants lack 2-hydroxylated sphingolipids (HFA-GalC and HFA-sulfatide) as evaluated by thin-layer chromatography and MALDI-TOF mass spectrometry (60) . 
Fatty acid and plasmalogen disorders
Several disorders in fatty acid metabolism are associated with defects in myelin that are mostly caused by the accumulation of lipids (Table 2, Figure 5 ). In 
Mouse models of fatty acid disorders:
As shown in Figure 2 , myelin is specifically enriched in saturated VLCFAs 
Mouse models of plasmalogen disorders:
The Pex2, Pex5 or Pex13 knockout mouse models of peroxisome biogenesis disorder have reduced nervous system plasmalogen levels (78-81), but how this contributes to myelin lipid defects is difficult to establish, due to the contribution of the other defects in peroxisome lipid metabolism ( Figure 5 ). The Pex7 (77) and dihydroxyacetone phosphate acyl transferase (89) knockout mice were generated as mouse models of rhizomeluic chondrodysplasia (RCDP) type 1 and 2, respectively, both peroxisomal disorders that are characterized by a shortage of ether lipids and delays in myelination (80) . In Pex7 knockout mice, a small reduction in CNS myelin protein levels was observed, and PNS nerves showed thinning of the myelin sheath and a reduced motor nerve conduction velocity (76) . In the knockout mouse for DHAPAT, a peroxisomal enzyme essential for plasmalogen synthesis, reduced CNS myelination was observed together with abnormal paranodal structure and reduced corpus callosum conduction velocity (90) . Together, these studies suggest a structural role of plasmalogens in myelin membrane, although ultrastructural studies remain necessary to unravel the precise role of plasmalogens in myelination.
Furthermore, plasmalogens are described to function as a sink of poly unsaturated fatty acids (PUFA) (91) and as such proposed to have a protective role against the effects of PUFA accumulation as seen in peroxisome disorders (92) . Indeed, Pex7:Abcd1 knockout mice show an increase in VLCFA accumulation and inflammatory demyelination (76) .
General lipogenesis disorders
Several myelin disorders are caused by defects in early steps in the synthesis of lipids ( PNS myelin defects have not been described. Canavan disease (CD (98)) is caused by a mutation in aspartoacylase (ASPA), an enzyme that in the rodent nervous system was shown to be predominantly expressed in oligodendrocytes (99) and is involved in the deacetylation of the nervous system specific metabolite Nacetylaspartic acid (NAA), thus generating free acetate in the brain. Patients affected by CD show accumulation of neuronal NAA and reduced levels of acetate in oligodendrocytes, the latter is generally thought to limit fatty acid and membrane lipid synthesis and to underlie the spongiform myelin degeneration, while leaving neurons intact (100, 101).
Mouse models of general lipid disorders:
Two mouse models of CD, in which ASPA is deleted, show myelin vacuolization similar to human Canavan patients (102, 103) , and reduced brain levels for acetate, myelin lipids and myelin proteins (104, 105) . Labeling studies have
shown that NAA is a major source of acetate for lipid synthesis during brain development and that neuronal-derived NAA supplies acetyl groups for myelin lipid synthesis (106, 107) . Its quantitative significance of for myelin synthesis is not completely clear also because in most cell types, the enzyme ATP-citrate lyase provides the acetyl groups for fatty acid synthesis. (104) suggested that the lowering of acetate in ASPA knockout mice is sufficient to decrease myelin synthesis.
However, ultrastructural analysis of myelin during development remains to be done in order to determine the precise consequence of ASPA deficiency on myelin formation.
Recently, it was shown that defective survival and differentiation of immature oligodendrocytes may as well be implicated in CD (108) . Also, importantly, the toxic effects of NAA in myelin vacuolization should not be neglected (109) .
The role of glial lipid synthesis in myelination was recently studied by Verheijen et al (110) . It was shown that the acute phase of myelin lipid synthesis is regulated by sterol regulatory element-binding protein (SREBP) cleavage activating protein (SCAP), an activator of SREBPs. P0cre-SCAP mice, which carry a Schwann cell specific deletion of SCAP, showed congenital hypomyelination, and had a loss of SREBP-mediated gene expression involved in cholesterol and fatty acids synthesis.
Interestingly, SCAP mutant Schwann cells were able to slowly synthesize myelin, in an external lipid-dependent fashion, resulting in myelin membrane defects that were associated with abnormal lipid composition. Saturated VLCFAs (C22:0 and C24:0)
were found to be reduced in myelin membranes, while poly-unsaturated fatty acids Together, these data suggest that lipids may control insulation of the axon and proper structure of the myelin membrane (Figure 7) . Both of these aspects are clearly affected in many lipid metabolic disorders, but it remains to be determined whether small functional defects on nerve function in certain cases are caused by more subtle changes in myelin lipid composition that affect axonal insulation. It is furthermore tempting to speculate that myelinating glial cells may control nerve conduction velocity by regulation of its myelin lipid content.
Timely myelination requires extraordinary high level of lipid synthesis together with uptake of extracellular lipids
Much of the vulnerability of myelin for lipid defects is caused by the fact that remains to be determined, but is likely to be small (Figure 7) . Defects in glial lipid synthesis will therefore consequently lead to defective myelin membrane synthesis.
Myelin lipids regulate the transport and localization of myelin proteins
In addition to the above mentioned synchronized expression of transcripts encoding structural myelin proteins and enzymes involved in myelin lipid biosynthesis, recent data suggest that glial lipid levels regulate myelin protein trafficking and thus also myelin assembly (52)(129). In oligodendrocytes, proteolipid protein (PLP) associates with lipid rafts before exiting the Golgi apparatus, suggesting that myelin lipid and proteins assemble in the Golgi complex, the cholesterol-and galactosylceramide-rich lipid rafts were shown to be required for proper sorting of PLP to myelin (129) . In line with this, certain mutations in PLP perturb interactions with cholesterol and lipid rafts, which may contribute to dysmyelination as found in spastic paraplegia (130) . Similarly, disrupted Schwann cell cholesterol biosynthesis led to partial mislocalization of myelin protein P0, resulting in non-compaction of the myelin membrane and hypomyelination (52) .
Additional cell culture experiments demonstrated that this defect could be restored by cholesterol supplementation, and showed the critical role of the myelin protein P0 cholesterol recognition/interaction amino acid consensus (CRAC) motif for its correct trafficking from endoplasmic reticulum to the myelin compartment. Furthermore, elevation of extracellular cholesterol or lipoproteins levels was demonstrated to increase myelination by Schwann cells in vitro (52, 110) . Together, these data suggest that lipids may control myelin protein trafficking and thereby assembly and compaction of the myelin membrane (Figure 7) . This lipid-mediated control mechanism of myelin protein sorting is like to be deregulated in lipid metabolic disorders, but whether and how it is used by myelinating glial cells to control myelin membrane synthesis under healthy conditions remains to be determined.
Lipids regulate differentiation of myelinating glial cells
The 
Myelin lipids as determinants for nerve fiber function
The process of myelination represents an interesting paradigm to study the metabolism and transport of lipids. Myelination by rodent glial cells is, both in vivo and in vitro, finalized within one to two weeks interval. Since during this period a myelinating glial cell needs to expand its membrane up to 6500 times, one can consider these cells as "lipid producing factories". For instance, transcriptional analysis of myelinating glial cells clearly revealed that the most co-regulated group of genes expressed during the period of myelination are lipid biosynthesis related transcripts (23, 24) .
Lipids as markers for myelin membrane integrity and function
Much of the structure and function of myelin is dependent on its lipid content.
Lipids may therefore be used as markers for myelin membrane integrity and associated nerve fiber function. The C18:1/C18:2 ratio is a well described marker for the progression of myelination of the PNS (7) 
Myelin lipids provide direct support to axonal function; an hypothesis
A possible role of myelinating glial cells in trophic support of underlying axons was recently suggested (135) . Previous data demonstrated that inactivation of peroxisomal biogenesis factor 5 (Pex5) led to generation of animals with disrupted peroxisomal function in oligodendrocytes and Schwann cells (see above, (82)).
Interestingly, while the affected animals were able to assemble normal myelin, they developed progressive axonal loss followed by demyelination. Based on these data it was suggested that the observed axonal loss could be, at least partially, a consequence of disrupted glial β-oxidation normally executed in peroxisomes, leading to diminished capacity to metabolically support the underlying axons (73) . A similar hypothesis suggesting the role of lipids in "energy-on-demand" supply for show that myelinating glial cells are able to take up lipids from the extracellular environment (51, 52, 144) . This is however complicated by the blood-nerve barrier and the blood-brain-barrier that shield respectively the PNS and CNS from lipids in the circulation (145, 146) . Therefore, the nervous system is classically viewed as and gray numbered lipids depict, respectively, strongly higher or lower levels of these fatty acids in myelin compared to hepatocytes or erythrocyte membranes. Myelin membrane of mouse sciatic nerve were isolated as described in (110, 157) . Mouse erythrocyte membranes and hepatocyte phospholipids were isolated and analyzed according to (110, 157) . It should be noted that under the isolation conditions used, amide bond in sphingolipids are relatively stable. Hence, the very long chain fatty acids found in myelin, are not reflecting the high level of galactosphingolipids in myelin, but more likely to result from a particular fatty acyl composition of the glycerophospholipids (PC, PE, PI, PS) . In addition, with the detection method used, the bar representing 18:1 fatty acids does not include 18:1 alcohol of plasmalogens, which nevertheless was previously detected to be very low in PNS myelin in mouse (110) 
